Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00961 | β-D-tetraacetylgalactopyranoside-PEG1-N3 | 153252-36-9 |
| β-D-tetraacetylgalactopyranoside-PEG1-N3 is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00962 | Amino-PEG11-alcohol | 15332-94-2 |
| Amino-PEG11-alcohol is a PEG linker containing an amino group. The amino group can react with carboxylic acids, activated NHS esters, carbonyls and so on. | Inquiry | |
| BADC-00963 | 4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid | 1537891-69-2 |
| 4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid is a pyridyl disulfide-containing ADC linker facilitating cleavable conjugation with antibodies, enabling controlled payload release and increased ADC selectivity and cytotoxicity in tumor cells. | Inquiry | |
| BADC-00964 | Aminoethyl-SS-propionic acid | 15579-00-7 |
| Aminoethyl-SS-propionic acid is a disulfide-based cleavable linker ideal for constructing ADCs. Its thiol-sensitive bond enables selective intracellular drug release, making it suitable for redox-responsive bioconjugation and targeted delivery systems in oncology. | Inquiry | |
| BADC-00965 | Aminoethyl-SS-ethylalcohol | 15579-01-8 |
| Aminoethyl-SS-ethylalcohol is a cleavable disulfide ADC linker with amine and alcohol functional groups for versatile antibody conjugation. Supports targeted drug delivery in ADC development with controlled release mechanisms. | Inquiry | |
| BADC-00966 | Mal-PEG4-VC-PAB-DMEA | 1569261-93-3 |
| Mal-PEG4-VC-PAB-DMEA is a maleimide-based cleavable ADC linker featuring valine-citrulline for enzymatic release. It provides stable antibody conjugation and efficient payload delivery in antibody-drug conjugates for precision oncology. | Inquiry | |
| BADC-00968 | MC-Val-Cit-PAB | 159857-80-4 |
| MC-Val-Cit-PAB is a widely used cleavable dipeptide linker in antibody-drug conjugates. Featuring a maleimide for thiol coupling and a Val-Cit-PAB trigger for enzymatic cleavage, it enables tumor-specific drug release and is key to many clinically approved ADCs. | Inquiry | |
| BADC-00969 | Val-Cit | 159858-33-0 |
| Val-Cit is a widely used cleavable dipeptide ADC linker enabling protease-sensitive payload release. Essential for antibody-drug conjugate development targeting tumor-specific environments with high therapeutic precision. | Inquiry | |
| BADC-00970 | MC-Gly-Gly-Phe | 1599440-15-9 |
| MC-Gly-Gly-Phe is a protease-sensitive ADC linker facilitating controlled drug release within tumor environments, enhancing the efficacy and safety profiles of antibody-drug conjugates. | Inquiry | |
| BADC-00973 | Boc-Dap-NE | 160800-65-7 |
| Boc-Dap-NE is a protected amino-functionalized ADC linker intermediate used in the synthesis of site-specific antibody conjugates for improved drug delivery and stability. | Inquiry | |
| BADC-00974 | TCO-PEG4-NHS ester | 1613439-69-2 |
| TCO-PEG4-NHS ester enables rapid click chemistry conjugation through its TCO group and amine-reactive NHS ester. It is widely used as an ADC linker in pretargeted drug delivery strategies. | Inquiry | |
| BADC-00976 | MC-VC-PAB-NH2 | 1616727-20-8 |
| MC-VC-PAB-NH2 is a maleimide-activated cleavable ADC linker with Val-Cit dipeptide and PAB spacer, featuring terminal amine for efficient antibody conjugation and selective drug release. | Inquiry | |
| BADC-00977 | Azide-C2-SS-C2-biotin | 1620523-64-9 |
| Azide-C2-SS-C2-biotin is a versatile ADC linker featuring cleavable disulfide bonds and biotin for targeted antibody conjugation. Ideal for precise payload delivery in ADC development, enhancing bioconjugation efficiency and therapeutic specificity in cancer treatment research. | Inquiry | |
| BADC-00978 | MC-Val-Ala-PAB-PNP | 1639939-40-4 |
| MC-Val-Ala-PAB-PNP is a peptide ADC linker with maleimide for thiol conjugation and valine-alanine for protease cleavage, enabling targeted payload release in antibody-drug conjugates. | Inquiry | |
| BADC-00979 | t-Boc-N-amido-PEG1-bromide | 164332-88-1 |
| t-Boc-N-amido-PEG1-bromide is a PEG linker containing a bromide group and a Boc-protected amino group. The hydrophilic PEG spacer increases solubility in aqueous media. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The Boc group can be deprotected under mild acidic conditions to form the free amine. | Inquiry | |
| BADC-00980 | Fmoc-Phe-Lys(Boc)-PAB-PNP | 1646299-50-4 |
| Fmoc-Phe-Lys(Boc)-PAB-PNP is a protected dipeptide ADC linker with a PNP leaving group for efficient payload conjugation. Featuring a self-immolative PAB unit, it ensures controlled drug release, supporting versatile bioconjugation strategies in targeted therapeutics. | Inquiry | |
| BADC-00981 | t-Boc-N-amido-PEG2-bromide | 165963-71-3 |
| t-Boc-N-amido-PEG2-bromide is a PEG linker containing a bromide group and a Boc-protected amino group. The hydrophilic PEG spacer increases solubility in aqueous media. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The Boc group can be deprotected under mild acidic conditions to form the free amine. | Inquiry | |
| BADC-00985 | Sulfo-SPDP-C6-NHS sodium | 169751-10-4 |
| Sulfo-SPDP-C6-NHS sodium is a cleavable ADC linker ideal for antibody-drug conjugates requiring disulfide bond release. This NHS-activated crosslinker enables stable amide bond formation with primary amines, widely used in bioconjugation, drug delivery, and targeted therapeutic development. | Inquiry | |
| BADC-00986 | mPEG7-amine | 170572-38-0 |
| mPEG7-amine is a linear PEG linker featuring a terminal amine group, suitable for site-specific ADC payload conjugation. The PEG7 chain increases hydrophilicity and reduces aggregation, improving antibody-drug conjugate efficacy and circulation time. | Inquiry | |
| BADC-00988 | Tetrazine-biotin | 1714123-51-9 |
| Tetrazine-biotin acts as a specialized ADC linker combining tetrazine bioorthogonal reactivity and biotin affinity for site-specific conjugation and efficient purification in ADC workflows. | Inquiry |
